TY - JOUR AU - Tapper, H. AU - Herwald, M. PY - 2000 DA - 2000// TI - Modulation of hemostatic mechanisms in bacterial infectious diseases JO - Blood VL - 96 ID - Tapper2000 ER - TY - JOUR AU - Creasey, A. A. PY - 1999 DA - 1999// TI - New potential therapeutic modalities: tissue factor pathway inhibitor JO - Sepsis VL - 3 UR - https://doi.org/10.1023/A:1009811819077 DO - 10.1023/A:1009811819077 ID - Creasey1999 ER - TY - JOUR AU - Pol, T. v. a. n. d. e. r. PY - 2008 DA - 2008// TI - Tissue factor as an initiator of coagulation and inflammation in the lung JO - Crit Care VL - 12 UR - https://doi.org/10.1186/cc7026 DO - 10.1186/cc7026 ID - Pol2008 ER - TY - JOUR AU - Welty-Wolf, K. E. AU - Carraway, M. S. AU - Miller, D. L. AU - Ortel, T. L. AU - Ezban, M. AU - Ghio, A. J. AU - Idell, S. AU - Piantadosi, C. A. PY - 2001 DA - 2001// TI - Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons JO - Am J Respir Crit Care Med VL - 164 UR - https://doi.org/10.1164/ajrccm.164.10.2105027 DO - 10.1164/ajrccm.164.10.2105027 ID - Welty-Wolf2001 ER - TY - JOUR AU - Mandell, L. A. AU - Wunderink, R. G. AU - Anzueto, A. PY - 2007 DA - 2007// TI - Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults JO - Clin Infect Dis VL - 44 UR - https://doi.org/10.1086/511159 DO - 10.1086/511159 ID - Mandell2007 ER - TY - JOUR PY - 2001 DA - 2001// TI - British Thoracic Society Guidelines for the management of community acquired pneumonia in adults JO - Thorax VL - 56 UR - https://doi.org/10.1136/thorax.56.4.250 DO - 10.1136/thorax.56.4.250 ID - ref6 ER - TY - JOUR AU - Matyal, R. AU - Mahmood, F. AU - Park, K. W. PY - 2005 DA - 2005// TI - Tifacogin, recombinant tissue factor pathway inhibitor JO - Int Anesthesiol Clin VL - 43 UR - https://doi.org/10.1097/01.aia.0000157499.41843.a3 DO - 10.1097/01.aia.0000157499.41843.a3 ID - Matyal2005 ER - TY - JOUR AU - Creasey, A. A. AU - Chang, A. C. AU - Feigen, L. AU - Wun, T. C. AU - Taylor, F. B. AU - Hinshaw, L. B. PY - 1993 DA - 1993// TI - Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock JO - J Clin Invest VL - 91 UR - https://doi.org/10.1172/JCI116529 DO - 10.1172/JCI116529 ID - Creasey1993 ER - TY - JOUR AU - Enkhbaatar, P. AU - Okajima, K. AU - Murukami, K. AU - Uchiba, M. AU - Okabe, H. AU - Okabe, K. AU - Yamaguchi, Y. PY - 2000 DA - 2000// TI - Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation JO - Am J Respir Crit Care Med VL - 162 UR - https://doi.org/10.1164/ajrccm.162.5.9911018 DO - 10.1164/ajrccm.162.5.9911018 ID - Enkhbaatar2000 ER - TY - JOUR AU - Miller, D. L. AU - Welty-Wolf, K. AU - Carraway, M. S. AU - Ezban, M. AU - Ghio, A. AU - Suliman, N. AU - Piantadosi, C. A. PY - 2002 DA - 2002// TI - Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intra-tracheal lipopolysaccharide JO - Am J Resp Cell Mol Biol VL - 26 UR - https://doi.org/10.1165/ajrcmb.26.6.4688 DO - 10.1165/ajrcmb.26.6.4688 ID - Miller2002 ER - TY - JOUR AU - Park, C. T. AU - Creasey, A. A. AU - Wright, S. D. PY - 1997 DA - 1997// TI - Tissue factor pathway inhibitor blocks cellular effects of endotoxin by binding to endotoxin and interfering with transfer to CD14 JO - Blood VL - 89 ID - Park1997 ER - TY - JOUR AU - Abraham, E. AU - Reinhart, K. AU - Svoboda, P. AU - Seibert, A. AU - Olthoff, D. AU - Dal Nogare, A. AU - Postier, R. AU - Hempelmann, G. AU - Butler, T. AU - Martin, E. AU - Zwingelstein, C. AU - Percell, S. AU - Shu, V. AU - Leighton, A. AU - Creasey, A. A. PY - 2001 DA - 2001// TI - Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study JO - Crit Care Med VL - 29 UR - https://doi.org/10.1097/00003246-200111000-00007 DO - 10.1097/00003246-200111000-00007 ID - Abraham2001 ER - TY - JOUR AU - Abraham, E. AU - Reinhart, K. AU - Opal, S. AU - Demeyer, I. AU - Doig, C. AU - Rodriguez, A. L. AU - Beale, R. AU - Svoboda, P. AU - Laterre, P. F. AU - Simon, S. AU - Light, B. AU - Spapen, H. AU - Stone, J. AU - Seibert, A. AU - Peckelsen, C. AU - De Deyne, C. AU - Postier, R. AU - Pettila, V. AU - Artigas, A. AU - Percell, S. R. AU - Shu, V. AU - Zwingelstein, C. AU - Tobias, J. AU - Poole, L. AU - Stolzenbach, J. C. AU - Creasey, A. A. PY - 2003 DA - 2003// TI - Efficacy and safety of tifacogin (recombinant tissue factor inhibitor) in severe sepsis: a randomized controlled trial JO - JAMA VL - 290 UR - https://doi.org/10.1001/jama.290.2.238 DO - 10.1001/jama.290.2.238 ID - Abraham2003 ER - TY - JOUR AU - Enjyoji, K. AU - Miyata, T. AU - Kamikubo, Y. AU - Kato, H. PY - 1995 DA - 1995// TI - Effect of heparin on the inhibition of factor Xa by tissue factor pathway inhibitor: a segment, Gly 212-Phe243, of the third Kunitz domain is a heparin-binding site JO - Biochemistry VL - 34 UR - https://doi.org/10.1021/bi00017a004 DO - 10.1021/bi00017a004 ID - Enjyoji1995 ER - TY - STD TI - Wunderink RG, Laterre PF, Larosa SP, Xie F, Poole L, Opal S: Severity of illness does not affect response to tifacogin in severe community-acquired pneumonia. AJRCCM 2006, (supplement abstract):A651. ID - ref15 ER -